SEC Form 4 · accession 0001140361-17-043343
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 16, 2017
Accepted (ET)
Nov 20, 2017 · 1:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | holding | — | — | — | 211,065 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $84.98 | Nov 16, 2017 | A | 102,781 | A | Nov 11, 2018 | Nov 16, 2024 | ResMed Common Stock | 102,781 | 102,781 | D |
Explanation of responses
- F1Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2018, 2019 and 2020.